Thrivent Financial for Lutherans’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,819
| Closed | -$620K | – | 2558 |
|
|
2023
Q1 | $620K | Sell |
6,819
-66,555
| -91% | -$6.05M | ﹤0.01% | 2036 |
|
|
2022
Q4 | $2.79M | Buy |
73,374
+36,156
| +97% | +$1.37M | 0.01% | 1048 |
|
|
2022
Q3 | $935K | Buy |
+37,218
| New | +$935K | ﹤0.01% | 1725 |
|
|
2021
Q4 | – | Sell |
-39,135
| Closed | -$3.94M | – | 2546 |
|
|
2021
Q3 | $3.94M | Sell |
39,135
-75
| -0.2% | -$7.55K | 0.01% | 995 |
|
|
2021
Q2 | $5.55M | Sell |
39,210
-12,211
| -24% | -$1.73M | 0.01% | 870 |
|
|
2021
Q1 | $5.13M | Sell |
51,421
-2,192
| -4% | -$219K | 0.01% | 907 |
|
|
2020
Q4 | $6.63M | Buy |
53,613
+39,824
| +289% | +$4.92M | 0.02% | 777 |
|
|
2020
Q3 | $1.34M | Sell |
13,789
-818
| -6% | -$79.7K | ﹤0.01% | 1392 |
|
|
2020
Q2 | $2.28M | Hold |
14,607
| – | – | 0.01% | 992 |
|
|
2020
Q1 | $2.11M | Buy |
+14,607
| New | +$2.11M | 0.01% | 929 |
|